Table 1.
Descriptive characteristics and bloodborne data of pre-diabetic subjects before and after an eight week intervention of ALCA or placebo
| Variable | Pre Intervention ALCA | Post Intervention ALCA | Pre Intervention Placebo | Post Intervention Placebo |
| Age (yrs) | 31 ± 3 | 31 ± 3 | 35 ± 3 | 35 ± 3 |
| Height (cm) | 172 ± 3 | 172 ± 3 | 169 ± 3 | 169 ± 3 |
| Weight (kg) | 85 ± 4 | 83 ± 5 | 91 ± 5 | 90 ± 4 |
| BMI (kg·m-2) | 28.5 ± 1.9 | 27.8 ± 1.7 | 31.7 ± 2.1 | 32.6 ± 2.4 |
| Body Fat (%) | 28 ± 2 | 26 ± 3 | 28 ± 2 | 27 ± 2 |
| Waist (cm) | 94 ± 4 | 92 ± 4 | 101 ± 5 | 100 ± 5 |
| Hip (cm) | 109 ± 4 | 106 ± 4 | 113 ± 5 | 111 ± 6 |
| Waist:Hip | 0.87 ± 0.05 | 0.87 ± 0.03 | 0.89 ± 0.04 | 0.90 ± 0.05 |
| Resting HR (bpm) | 73 ± 2 | 71 ± 2 | 73 ± 2 | 72 ± 3 |
| Resting SBP (mmHg) | 123 ± 1 | 121 ± 1 | 119 ± 1 | 118 ± 2 |
| Resting DBP (mmHg) | 79 ± 1 | 78 ± 1 | 80 ± 1 | 80 ± 1 |
| Glucose (mg·dL-1) | 109 ± 5 | 103 ± 5 | 112 ± 6 | 111 ± 5 |
| HbA1c (%) | 6.6 ± 1.9 | 6.2 ± 2.2 | 6.7 ± 1.8 | 6.6 ± 2.2 |
| Insulin (μU·mL-1) | 12.1 ± 1.8 | 11.4 ± 2.1 | 12.4 ± 1.9 | 12.7 ± 2.0 |
| HOMA-IR | 3.3 ± 1.3 | 2.9 ± 1.2 | 3.4 ± 1.4 | 3.5 ± 1.6 |
| Total Cholesterol (mg·dL-1) | 195 ± 13 | 192 ± 14 | 184 ± 14 | 179 ± 15 |
| HDL-C (mg·dL-1) | 51 ± 7 | 48 ± 6 | 47 ± 4 | 50 ± 5 |
| LDL-C (mg·dL-1) | 127 ± 13 | 132 ± 11 | 123 ± 8 | 117 ± 10 |
| CRP (ng·mL-1) | 1432 ± 342 | 1389 ± 328 | 1652 ± 408 | 1738 ± 425 |
Data are mean ± SEM.
No statistically significant differences noted (p > 0.05).